Publication: 2572

Publication: 2572

Early relapse of follicular lymphoma after rituximab-based biologic doublet upfront therapy is associated with increased risk of death: a combined analysis from CALGB/Alliance Studies 50402, 50701 and 50803

URL

URL

Google Scholar

Citation:: Blood vol 128 (22) abstr 2953

Meeting Instance:: ASH 2016
Year:: 2016
Type:: Abstract
Sub type:: Poster Discussion
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Meta-Analysis
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 2817

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:

Pharmas:: Celgene
Grants:: U10CA180821, U10CA180882

Corr. Author:
Authors:: Frederick Lansigan Ian Barak Brandelyn Pitcher Sin-Ho Jung Bruce Cheson Myron Czuczman Barbara Grant Peter Martin Eric Hsi Heiko Schroder Nancy Bartlett John P. Leonard Kristie A. Blum

Networks:: CAPITAL, LAPS-MN026, LAPS-MO011, LAPS-NH012, LAPS-NY158, LAPS-OH007, NY018

Study
Multiple Studies, or Legacy Studies in Alliance Study:: CALGB-50402, CALGB-50701, CALGB-50803
Phases:: 2

Keywords: